These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8221452)

  • 1. Statement on pertussis immunization. National Advisory Committee on Immunization.
    CMAJ; 1993 Oct; 149(8):1132-7. PubMed ID: 8221452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Advisory Committee on Immunization (NACI). Statement on pertussis immunization.
    Can Commun Dis Rep; 1993 Mar; 19(6):41-5. PubMed ID: 8481708
    [No Abstract]   [Full Text] [Related]  

  • 3. Statement on management of persons exposed to pertussis and pertussis outbreak control. The National Advisory Committee on Immunization, the Advisory Committee on Epidemiology and the Canadian Paediatric Society.
    Can Dis Wkly Rep; 1990 Jul; 16(27):127-30. PubMed ID: 2376069
    [No Abstract]   [Full Text] [Related]  

  • 4. The Australian College of Paediatrics Policy Statement. Contraindications to immunization against pertussis.
    J Paediatr Child Health; 1994 Aug; 30(4):310-1. PubMed ID: 7946540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Advisory Committee on Immunization (NACI). Supplementary statement MMR vaccine and anaphylactic hypersensitivity to egg or egg-related antigens.
    Can Commun Dis Rep; 1996 Jul; 22(14):113-5. PubMed ID: 8754935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
    Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraindications to vaccination in children. Mainly immunosuppression and a history of severe reactions.
    Prescrire Int; 2003 Jun; 12(65):103-7. PubMed ID: 12825597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Answers to questions about the acellular pertussis vaccine.
    Kimmel SR
    Am Fam Physician; 1993 Jun; 47(8):1825-32. PubMed ID: 8498289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommended childhood immunization schedule--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statement on management of persons exposed to pertussis and pertussis outbreak control. National Advisory Committee on Immunization, the Advisory Committee on Epidemiology and the Canadian Paediatric Society.
    Can Commun Dis Rep; 1994 Nov; 20(22):193-200. PubMed ID: 7841931
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study.
    Jacobson V; Nielsen C; Buch D; Shields WD; Christenson P; Zachau-Christiansen B; Cherry JD
    Tokai J Exp Clin Med; 1988; 13 Suppl():137-42. PubMed ID: 3273613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season.
    Can Commun Dis Rep; 1998 Jul; 24():1-12. PubMed ID: 10330776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis immunization and the central nervous system. Ad Hoc Committee for the Child Neurology Society Consensus Statement on Pertussis Immunization and the Central Nervous System.
    Ann Neurol; 1991 Apr; 29(4):458-60. PubMed ID: 1929219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Health Council of the Netherlands advisory report 'Vaccination against pertussis'--time for a new vaccine].
    Visser HK
    Ned Tijdschr Geneeskd; 2004 May; 148(19):916-8. PubMed ID: 15160555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Academy of Pediatrics Committee on Infectious Diseases: Pertussis vaccine.
    Pediatrics; 1984 Aug; 74(2):303-5. PubMed ID: 6462833
    [No Abstract]   [Full Text] [Related]  

  • 20. Supplementary statement of contraindications to receipt of pertussis vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Apr; 33(13):169-71. PubMed ID: 6422236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.